3-Hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones as new HIV-1 integrase inhibitors WO2011046873 A1

JOURNAL ARTICLE published November 2011 in Expert Opinion on Therapeutic Patents

Authors: Philippe Cotelle

Annotated Patent Selections

JOURNAL ARTICLE published August 2000 in Expert Opinion on Therapeutic Patents

JOURNAL ISSUE published August 1994 in Expert Opinion on Therapeutic Patents

Patent developments in anabolic agents for treatment of bone diseases

JOURNAL ARTICLE published August 2003 in Expert Opinion on Therapeutic Patents

Authors: John A Wos | Mark W Lundy

Company Profile Du Pont Merck: analysis of patenting 1993 - 1996

JOURNAL ARTICLE published December 1996 in Expert Opinion on Therapeutic Patents

Authors: Peter R Steele

Patent Evaluation: Targeted virus

JOURNAL ARTICLE published April 1994 in Expert Opinion on Therapeutic Patents

Oncologic, Endocrine & Metabolic: Novel antitumour drug conjugates

JOURNAL ARTICLE published July 1995 in Expert Opinion on Therapeutic Patents

Quinazolin-4(3H)-ones capable of upregulating the expression of endogenous apolipoprotein A-1

JOURNAL ARTICLE published March 2011 in Expert Opinion on Therapeutic Patents

Authors: Jianhui Wu | Ming Zhao | Shiqi Peng

Heterocycle derivatives that inhibit Factor Xa

JOURNAL ARTICLE published October 1998 in Expert Opinion on Therapeutic Patents

Therapeutic approaches to obesity

JOURNAL ARTICLE published December 1998 in Expert Opinion on Therapeutic Patents

Authors: John Dunlop | Sharon Rosenzweig-Lipson

Compounds and methods for inhibiting histone demethylases: a patent evaluation of US20160102096A1

JOURNAL ARTICLE published 1 December 2016 in Expert Opinion on Therapeutic Patents

Authors: Florian Thaler | Ciro Mercurio

PARP inhibitors as antitumor agents: a patent update (2013-2015)

JOURNAL ARTICLE published 4 March 2017 in Expert Opinion on Therapeutic Patents

Authors: Zigao Yuan | Jiwei Chen | Wenlu Li | Dan Li | Changjun Chen | Chunmei Gao | Yuyang Jiang

Biologicals & Immunologicals: Process for categorising nucleotide sequencing populations

JOURNAL ARTICLE published February 1995 in Expert Opinion on Therapeutic Patents

Company Profile: Part One Pharmacia: Analysis of Patenting 1992-1995

JOURNAL ARTICLE published November 1995 in Expert Opinion on Therapeutic Patents

Authors: Peter Steele

Inhibitors of neutrophil elastase

JOURNAL ARTICLE published July 1994 in Expert Opinion on Therapeutic Patents

Company Profile: Hoechst: Analysis of patenting 1991–1994

JOURNAL ARTICLE published November 1994 in Expert Opinion on Therapeutic Patents

Authors: Peter Steele

Pyrrolo[2,3-d]pyrimidines as inhibitors of pp60c-src

JOURNAL ARTICLE published March 1997 in Expert Opinion on Therapeutic Patents

The challenges of joint performance to method patents

JOURNAL ARTICLE published 3 April 2017 in Expert Opinion on Therapeutic Patents

Research funded by National Health Research Institutes (105-IPHS-PP06) | National Health Research Institutes (106-IPHS-PP06)

Authors: Feng-Chi Chen

Methods for increasing protein expression

JOURNAL ARTICLE published July 1997 in Expert Opinion on Therapeutic Patents

Cyclic sulfone hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α-converting enzymes

JOURNAL ARTICLE published January 2004 in Expert Opinion on Therapeutic Patents